1 |
Weir EK, Archer SL. The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J. 1995;9:183-189.
DOI
|
2 |
Archer SL, Wu XC, Thébaud B, Nsair A, Bonnet S, Tyrrell B, McMurtry MS, Hashimoto K, Harry G, Michelakis ED. Preferential expression and function of voltage-gated, -sensitive channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res. 2004;95:308-318.
DOI
ScienceOn
|
3 |
Osipenko ON, Tate RJ, Gurney AM. Potential role for kv3.1b channels as oxygen sensors. Circ Res. 2000;86:534-540.
DOI
ScienceOn
|
4 |
Sweeney M, Yuan JX. Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir Res. 2000;1:40-48.
DOI
ScienceOn
|
5 |
Yoo HY, Park SJ, Seo EY, Park KS, Han JA, Kim KS, Shin DH, Earm YE, Zhang YH, Kim SJ. Role of thromboxane -activated nonselective cation channels in hypoxic pulmonary vasoconstriction of rat. Am J Physiol Cell Physiol. 2012;302:C307-317.
DOI
ScienceOn
|
6 |
Pierson DJ. Pathophysiology and clinical effects of chronic hypoxia. Respir Care. 2000;45:39-51; discussion 51-53.
|
7 |
Pozeg ZI, Michelakis ED, McMurtry MS, Thébaud B, Wu XC, Dyck JR, Hashimoto K, Wang S, Moudgil R, Harry G, Sultanian R, Koshal A, Archer SL. In vivo gene transfer of the -sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation. 2003;107:2037-2044.
DOI
ScienceOn
|
8 |
Reeve HL, Michelakis E, Nelson DP, Weir EK, Archer SL. Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol (1985). 2001;90:2249-2256.
DOI
|
9 |
McMurtry IF, Petrun MD, Reeves JT. Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia. Am J Physiol. 1978;235:H104-109.
|
10 |
Asano K, Yanagidaira Y, Yoshimura K, Sakai A. The cGMP pathway is not responsible for the blunted hypoxic vasoconstriction in rat lungs after altitude exposure. Acta Physiol Scand. 1997;160:393-400.
DOI
ScienceOn
|
11 |
Moudgil R, Michelakis ED, Archer SL. The role of channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation. 2006;13:615-632.
DOI
ScienceOn
|
12 |
Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675-691.
DOI
ScienceOn
|
13 |
Laursen BE, Dam MY, Mulvany MJ, Simonsen U. Hypoxiainduced pulmonary vascular remodeling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration. Vascul Pharmacol. 2008;49:71-76.
DOI
ScienceOn
|
14 |
Weissmann N, Nollen M, Gerigk B, Ardeschir Ghofrani H, Schermuly RT, Gunther A, Quanz K, Fink L, Hanze J, Rose F, Seeger W, Grimminger F. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol. 2003;284:H931-938.
DOI
|
15 |
Yuan JX. Oxygen-sensitive channel(s): where and what? Am J Physiol Lung Cell Mol Physiol. 2001;281:L1345-1349.
DOI
|
16 |
Park SJ, Yoo HY, Kim HJ, Kim JK, Zhang YH, Kim SJ. Requirement of pretone by thromboxane a2 for hypoxic pulmonary vasoconstriction in precision-cut lung slices of rat. Korean J Physiol Pharmacol. 2012;16:59-64.
DOI
ScienceOn
|
17 |
Peng G, Lu W, Li X, Chen Y, Zhong N, Ran P, Wang J. Expression of store-operated entry and transient receptor potential canonical and vanilloid-related proteins in rat distal pulmonary venous smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2010;299:L621-630.
DOI
ScienceOn
|
18 |
Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, Olschewski A, Storch U, Mederos y Schnitzler M, Ghofrani HA, Schermuly RT, Pinkenburg O, Seeger W, Grimminger F, Gudermann T. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci U S A. 2006;103:19093-19098.
DOI
ScienceOn
|
19 |
Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci U S A. 2004;101:13861-13866.
DOI
ScienceOn
|
20 |
Urban N, Hill K, Wang L, Kuebler WM, Schaefer M. Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. Cell Calcium. 2012;51:194-206.
DOI
ScienceOn
|
21 |
Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol. 2004;287:L656-664.
DOI
ScienceOn
|
22 |
Naeije R, Barbera JA. Pulmonary hypertension associated with COPD. Crit Care. 2001;5:286-289.
DOI
ScienceOn
|
23 |
Zubieta-Castillo G Sr, Zubieta-Calleja GR Jr, Zubieta-Calleja L. Chronic mountain sickness: the reaction of physical disorders to chronic hypoxia. J Physiol Pharmacol. 2006;57 Suppl 4:431-442.
|
24 |
Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest. 2000;106:733-738.
DOI
ScienceOn
|
25 |
25. McGuire M, Bradford A. Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats. Eur Respir J. 2001;18:279-285.
DOI
|